Similar to prostate cancer, there are commercially available tumor markers in melanoma patients such as S100β, LDH, the protein “melanoma inhibitory activity” (MIA), CRO, PD-L1, IL-8, TIL, osteopontin, and YKL-40. The gene discussed is CXCL8; the disease is melanoma.